Charles River Laboratories International Inc (NYSE:CRL) shares, rose in value on Wednesday, May 07, with the stock price up by 18.68% to the previous day’s close as strong demand from buyers drove the stock to $136.97.
Actively observing the price movement in the last trading, the stock closed the session at $115.41. The PE ratio was 534.00 over 12-month period. Referring to stock’s 52-week performance, its high was $254.15, and the low was $91.86. On the whole, CRL has fluctuated by 2.16% over the past month.
With the market capitalization of Charles River Laboratories International Inc currently standing at about $6.73 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 3.86B, with a low estimate of 964.53M and a high estimate of 992.66M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 973.8M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CRL’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 194.89, with the price of CRL currently trading nearly 20.75% and -3.51% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 59.40, while the 7-day volatility ratio is showing 5.41% which for the 30-day chart, stands at 8.03%. Furthermore, Charles River Laboratories International Inc (CRL)’s beta value is 1.45, and its average true range (ATR) is 8.52.
A comparison of Charles River Laboratories International Inc (CRL) with its peers suggests the former has fared considerably weaker in the market. CRL showed an intraday change of 18.68% in last session, and over the past year, it shrunk by -41.33%%.
Data on historical trading for Charles River Laboratories International Inc (NYSE:CRL) indicates that the trading volumes over the past 3 months, they’ve averaged 1.73 million. According to company’s latest data on outstanding shares, there are 51.14 million shares outstanding.
Nearly 1.17% of Charles River Laboratories International Inc’s shares belong to company insiders and institutional investors own 108.73% of the company’s shares. The stock has fallen by -25.80% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRL stock heading into the next quarter.
